Ion channels are the third biggest target class in drug discovery. Primary research is continually uncovering novel disease indications including cancer, diabetes and
respiratory as well as new targets in the ‘traditional’ fields of pain and cardiovascular disease.
Official Website: http://www.iir-events.com/IIR-conf/LifeSciences/EventView.aspx?EventID=1969
Added by mBLAST on October 14, 2008